Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

Non-coding RNAs play key roles in the hair growth cycle of Angora rabbits.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Ruxolitinib treatment may cause eyelash growth.

Hair growth environment recreated with challenges; stem cells make successful skin organoids.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Mechanical surface cues can control macrophage behavior for better immunotherapy and tissue healing.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Vav2 changes how hair follicle stem cells' genes work as they age, which might improve regeneration but also raise cancer risk.

Skin healing from blisters can delay hair growth as stem cells focus on repairing skin over developing hair.

The research found that a specific skin cell type not only triggers hair growth but also controls hair color, and that aging can lead to hair loss and color changes.

Researchers found that the Leptin receptor is a consistent marker for hair follicle dermal cells, which may help future hair research.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Stem cell niches are adaptable and key for tissue maintenance and repair.